FDA black box warning on the use of 80 mg simvastatin: Difference between revisions
Jump to navigation
Jump to search
Kashish Goel (talk | contribs) No edit summary |
Kashish Goel (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
'''Editor-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org] Phone:617-632-7753; '''Associate Editor(s)-In-Chief:''' [[Kashish Goel|Kashish Goel, M.D.]] | '''Editor-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org] Phone:617-632-7753; '''Associate Editor(s)-In-Chief:''' [[Kashish Goel|Kashish Goel, M.D.]] | ||
__NOTOC__ | __NOTOC__ | ||
==Overview== | ==Overview== | ||
Simvastatin 80 mg is the highest approved dose for this drug and it is estimated that approximately 2.1 million patients in the U.S. were prescribes this dose in the year 2010<ref>http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm<ref>. Based on the review of randomized clinical trial, '''Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)''', FDA recommended limiting the use of high-dose simvastatin. | |||
Revision as of 20:31, 14 September 2011
Template:Hypercholesterolemia
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Kashish Goel, M.D.
Overview
Simvastatin 80 mg is the highest approved dose for this drug and it is estimated that approximately 2.1 million patients in the U.S. were prescribes this dose in the year 2010<ref>http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm<ref>. Based on the review of randomized clinical trial, Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH), FDA recommended limiting the use of high-dose simvastatin.